Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.03 USD | +5.25% | +20.76% | +112.91% |
Mar. 06 | Transcript : Inovio Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 06, 2024 | |
Mar. 06 | Inovio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+112.91% | 305M | |
+9.16% | 45.97B | |
+54.37% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |
- Stock
- Equities
- Stock Inovio Pharmaceuticals, Inc. - Nasdaq
- News Inovio Pharmaceuticals, Inc.
- Maxim Group Adjusts Inovio Pharmaceuticals Price Target to $11 From $20, Maintains Buy Rating